Ketamine, a controlled substance referred to as a party drug by those who abuse it, is now being used in authorised clinical settings in Singapore to treat patients with major depressive disorder (MDD) who are not responding well to other forms of treatment.
Esketamine has been approved by the authorities and used to treat two patients in Singapore. The modified version of ketamine is being administered via a nasal spray.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you